Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?

NCT03299855 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT03299855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03299855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?
Lead sponsor
Centre Francois Baclesse
Phase
Not applicable
Overall status
Completed
Start date
October 13, 2017
Completion date
October 13, 2023
Enrollment
104 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms